CUSIP 00434H108COMMON STOCKXLRNQ4 2025
14 filings · latest Nov 24, 2021
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 2 | $358 |
| 4 | Feb 16, 2021 | Price T Rowe Associates Inc /Md/ | 13G/A | 8.8% | 5.31M | SEC |
| 5 | Feb 10, 2021 | Vanguard Group Inc | 13G/A | 8.3% | 5.03M | SEC |
| 6 | Feb 8, 2021 | Fmr LLC | 13G/A | 7.8% | — | SEC |
| 7 | Jan 29, 2021 | Blackrock Inc. | 13G/A | 7.7% | 4.61M | SEC |
| 8 | Sep 10, 2020 | Fmr LLC | 13G/A | 9.8% | — | SEC |
| 9 | Jul 16, 2020 | Bristol Myers Squibb Co | 13D/A | 12.0% | 7.01M | SEC |
| 10 | Jun 9, 2020 | Blackrock Inc. | 13G/A | 10.0% | 5.39M | SEC |
See the full Schedule 13D/13G history for Acceleron Pharma Inc.
Unlock full history